SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCizzle Biotech Share News (CIZ)

Share Price Information for Cizzle Biotech (CIZ)

Share Price is delayed by 15 minutes
Get Live Data
2.95    0.20 (7.27%)
Bid:
2.80
Ask:
3.10
Spread: 0.30 (10.714%)
Market Cap: £12.54m
CIZ Live PriceLast checked at - London Stock Exchange

Intraday Cizzle Biotech Share Chart

Cizzle Biotech News

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising
16 Jun 2022

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs
30 May 2022

IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Posts higher annual loss in 2021. Pretax loss widens to GBP4.0 million from G...

AIM WINNERS & LOSERS: SDI upbeat; Westminster rises on contract win
6 May 2022

AIM WINNERS & LOSERS: SDI upbeat; Westminster rises on contract win

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Cizzle Biotechnology shares jump on US lung cancer collaboration
6 May 2022

Cizzle Biotechnology shares jump on US lung cancer collaboration

(Alliance News) - Cizzle Biotechnology Holdings PLC on Friday announced a new collaboration into lung cancer testing with a US partner.

TRADING UPDATES: WANdisco bookings up; STM legal appeal denied
11 Apr 2022

TRADING UPDATES: WANdisco bookings up; STM legal appeal denied

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

IN BRIEF: Cizzle Biotech notes promising data from Arcadia study
8 Mar 2022

IN BRIEF: Cizzle Biotech notes promising data from Arcadia study

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Reports that Arcadia clinical study shows potential value of AZD1656 treatmen...

Cizzle Biotechnology acquires further 5% interest in Covid treatment
14 Feb 2022

Cizzle Biotechnology acquires further 5% interest in Covid treatment

(Alliance News) - Cizzle Biotechnology Holdings PLC shares jumped on Monday after it announced that it acquired an additional 5% interest in the comme...